Migraine Trial, Recruiting NCT04628429 Sponsor: Medical University of Vienna Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT04628429
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with chronic migraine (frequent migraines occurring most days of the month)
  • You have been diagnosed with episodic migraine, either with or without warning symptoms (such as visual disturbances) before the headache
  • You have already tried 3 or more standard migraine prevention medications that did not work well enough for you
  • Your health insurance covers the cost of the medication used in this trial
  • If you are joining as a healthy volunteer (not a migraine patient), you must have no diagnosed long-term illness and no current infection that requires medication

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have had brain or nervous system surgery in the last 12 months
  • You have had heart bypass surgery or a procedure to restore blood flow to the heart in the last 12 months
  • You have a history of mini-strokes (TIA), stroke, chest pain conditions (angina), heart attack, or poorly controlled high blood pressure
  • You have a known allergy or sensitivity to a type of migraine treatment called anti-CGRP antibodies
  • You have a condition (other than migraine) that could affect the results of tests measuring your body's automatic functions, such as heart rate or blood pressure responses (confirm with trial site)
  • If you are joining as a healthy volunteer, neither you nor any close family member has a history of migraine

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christian Wöber, Prof. MD, Medical University of Vienna

Phone: +43 (0)1 40400 - 31170

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2020
Est. completion
1 December 2025

Where this trial is recruiting

🇦🇹 Austria

Primary endpoints

Change from Day 0 Cardiovagal Autonomic Dysfunction (CAD) at 5 months; Change from Days 1-31 Cardiovagal Autonomic Dysfunction (CAD) at 5 months; Change from Days 0 Cardiovagal Autonomic Dysfunction (CAD) at Days 1-31

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov